TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
KURN Stock 12 Month Forecast
Average Price Target
CHF38.00
▲(34.94% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Kuros Biosciences in the last 3 months. The average price target is CHF38.00 with a high forecast of CHF38.00 and a low forecast of CHF38.00. The average price target represents a 34.94% change from the last price of CHF28.16.
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -4.08% per trade.
Copying Christophe dombu's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -10.18% per trade.
trades and holding each position for 2 Years would result in 16.67% of your transactions generating a profit, with an average return of -10.18% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
KURN Analyst Recommendation Trends
Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
0
0
0
0
1
Buy
3
2
1
1
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
2
1
1
2
In the current month, KURN has received 2Buy Ratings, 0Hold Ratings, and 0Sell Ratings. KURN average Analyst price target in the past 3 months is 38.00.
Each month's total comprises the sum of three months' worth of ratings.
KURN Financial Forecast
KURN Earnings Forecast
The previous quarter’s earnings for KURN were CHF0.09.
The previous quarter’s earnings for KURN were CHF0.09.
KURN Sales Forecast
Next quarter’s sales forecast for KURN is CHF72.07M with a range of CHF72.07M to CHF72.07M. The previous quarter’s sales results were CHF66.04M. KURN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year KURN has Performed in-line its overall industry.
Next quarter’s sales forecast for KURN is CHF72.07M with a range of CHF72.07M to CHF72.07M. The previous quarter’s sales results were CHF66.04M. KURN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year KURN has Performed in-line its overall industry.
KURN Stock Forecast FAQ
What is CH:KURN’s average 12-month price target, according to analysts?
Based on analyst ratings, Kuros Biosciences Ltd.’s 12-month average price target is 38.00.
What is CH:KURN’s upside potential, based on the analysts’ average price target?
Kuros Biosciences Ltd. has 34.94% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Kuros Biosciences Ltd. a Buy, Sell or Hold?
Kuros Biosciences Ltd. has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Kuros Biosciences Ltd.’s share price target?
The average share price target for Kuros Biosciences Ltd. is 38.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF38.00 ,and the lowest forecast is CHF38.00. The average share price target represents 34.94% Increase from the current price of CHF28.16.
What do analysts say about Kuros Biosciences Ltd.?
Kuros Biosciences Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of Kuros Biosciences Ltd.?
To buy shares of CH:KURN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.